Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163746 · ClinicalTrials.gov registry record · NA
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02163746 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 20 participants.
The verdict
NCT02163746, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study compares two well-known treatment options for Stage 2 hidradenitis suppurativa: carbon dioxide (CO2) laser excision versus surgical deroofing.
Interventions
- PROCEDURE CO2 (carbon dioxide) laser
- PROCEDURE Surgical Deroofing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-01-14 |
| Est. Completion | 2016-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163746
The ClinicalTrials.gov registry entry for NCT02163746 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CO2 (carbon dioxide) laser is the first listed.
NCT02163746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02163746 about?
NCT02163746 is a clinical study titled "Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing". This study compares two well-known treatment options for Stage 2 hidradenitis suppurativa: carbon dioxide (CO2) laser excision versus surgical deroofing.
What is the current status of trial NCT02163746?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-01-14. Estimated completion is 2016-06-07.
What interventions are being tested in trial NCT02163746?
The interventions under investigation include: CO2 (carbon dioxide) laser (PROCEDURE), Surgical Deroofing (PROCEDURE).
Who is sponsoring clinical trial NCT02163746?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.